Investegate |ProMIS Neurosciences Inc. Announcements | ProMIS Neurosciences Inc.: ProMIS Neurosciences Offers Perspectives on Recent Progress in the Alzheimer's/Amyloid Field
ProMIS Neurosciences Offers Perspectives on Recent Progress in the Alzheimer’s/Amyloid Field Two positive events in January support PMN310 “best in class” positioning TORONTO and CAMBRIDGE, Mass., Feb. 02, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced today its perspectives on recent progress in the Alzheimer’s field. Two important events occurred in January 2021, bo...
Source: investegate.co.uk